145 related articles for article (PubMed ID: 1828756)
1. Antibiotic resistance of Clostridium difficile isolates.
Dworczyński A; Sokół B; Meisel-Mikołajczyk F
Cytobios; 1991; 65(262-263):149-53. PubMed ID: 1828756
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial activity of teicoplanin against Clostridium difficile.
Wongwanich S; Kusum M; Phan-Urai R
Southeast Asian J Trop Med Public Health; 1996 Sep; 27(3):606-9. PubMed ID: 9185278
[TBL] [Abstract][Full Text] [Related]
3. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].
Poilane I; Fantinato C; Cruaud P; Collignon A
Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360
[TBL] [Abstract][Full Text] [Related]
4. [Survey of susceptibility of clinical Clostridium diffiicile strains isolated from patients hospitalised in different departments of paediatric hospital to antimicrobial agents].
Wultańska D; Obuch-Woszczatyński P; Pituch H; Luczak M
Med Dosw Mikrobiol; 2007; 59(2):161-8. PubMed ID: 17929413
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of susceptibility to metronidazole and vancomycin of Clostridium difficile strains isolated between 1998-2002].
Pituch H; Obuch-Woszczatyński P; Glinka D; Łazińska B; Meisel-Mikołajczyk F; Łuczak M
Med Dosw Mikrobiol; 2003; 55(3):253-8. PubMed ID: 14702667
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility of Clostridium difficile by E test.
Cheng SH; Chu FY; Lo SH; Lu JJ
J Microbiol Immunol Infect; 1999 Jun; 32(2):116-20. PubMed ID: 11561576
[TBL] [Abstract][Full Text] [Related]
7. [Antimicrobial susceptibility of Clostridium difficile clinical isolates collected from 2001 to 2007 in a French university hospital].
Cattoir V; Ould-Hocine ZF; Legrand P
Pathol Biol (Paris); 2008; 56(7-8):407-11. PubMed ID: 18845403
[TBL] [Abstract][Full Text] [Related]
8. [Occurrence of Clostridium difficile in feces of children with dysfunction of the digestive tract and other disorders].
Pykiel M; Dzierzanowska D; Stafiej-Modrawska E; Kulesza E; Orłowski L
Med Dosw Mikrobiol; 1990; 42(1-2):10-4. PubMed ID: 2087130
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial resistance of Clostridium difficile isolates in a tertiary medical center, Israel.
Bishara J; Bloch Y; Garty M; Behor J; Samra Z
Diagn Microbiol Infect Dis; 2006 Feb; 54(2):141-4. PubMed ID: 16406180
[TBL] [Abstract][Full Text] [Related]
10. [Interest of the disk diffusion method for screening Clostridium difficile isolates with decreased susceptibility to antibiotics].
Poilane I; Bert F; Cruaud P; Nicolas-Chanoine MH; Collignon A
Pathol Biol (Paris); 2007 Nov; 55(8-9):429-33. PubMed ID: 17905536
[TBL] [Abstract][Full Text] [Related]
11. [Drug resistance of 100 clinical strains of Enterococcus spp].
Sawicka-Grzelak A; Rokosz A; Luczak M
Med Dosw Mikrobiol; 1999; 51(3-4):239-47. PubMed ID: 10803253
[TBL] [Abstract][Full Text] [Related]
12. New PCR ribotypes of Clostridium difficile detected in children in Brazil: prevalent types of Clostridium difficile in Brazil.
Alcides AP; Brazier JS; Pinto LJ; Balassiano IT; Boente RF; de Paula GR; Ferreira EO; Avelar KE; Miranda KR; Ferreira MC; Domingues RM
Antonie Van Leeuwenhoek; 2007 Jul; 92(1):53-9. PubMed ID: 17252315
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin.
O'Connor R; Baines SD; Freeman J; Wilcox MH
J Antimicrob Chemother; 2008 Oct; 62(4):762-5. PubMed ID: 18606787
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest.
Wong SS; Woo PC; Luk WK; Yuen KY
Diagn Microbiol Infect Dis; 1999 May; 34(1):1-6. PubMed ID: 10342100
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993-2007 in Sweden.
Norén T; Alriksson I; Akerlund T; Burman LG; Unemo M
Clin Microbiol Infect; 2010 Aug; 16(8):1104-10. PubMed ID: 19732094
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic studies of vancomycin, metronidazole and fusidic acid against Clostridium difficile.
Odenholt I; Walder M; Wullt M
Chemotherapy; 2007; 53(4):267-74. PubMed ID: 17595541
[TBL] [Abstract][Full Text] [Related]
17. [Detection of ermB gene responsible for high level resistance to clindamycin (MLS type resistance) among Clostridium difficile strains isolated from antibiotic associated diarrhea (AAD)].
Pituch H; Obuch-Woszczatyński P; Meisel-Mikołajczyk F; Łuczak M
Med Dosw Mikrobiol; 2003; 55(1):61-6. PubMed ID: 12908416
[TBL] [Abstract][Full Text] [Related]
18. In vitro effect of metronidazole and vancomycin in combination on Clostridium difficile.
Hames A; Perry JD; Gould FK
J Antimicrob Chemother; 2009 May; 63(5):1076. PubMed ID: 19240074
[No Abstract] [Full Text] [Related]
19. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from hospitals during a 4-year period in China.
Chen YB; Gu SL; Shen P; Lv T; Fang YH; Tang LL; Li LJ
J Med Microbiol; 2018 Jan; 67(1):52-59. PubMed ID: 29160203
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of daptomycin, vancomycin, and penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes.
Tyrrell KL; Citron DM; Warren YA; Fernandez HT; Merriam CV; Goldstein EJ
Antimicrob Agents Chemother; 2006 Aug; 50(8):2728-31. PubMed ID: 16870765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
